{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T01:13:16Z","timestamp":1785028396623,"version":"3.55.0"},"reference-count":132,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100013314","name":"111 Project of MOE","doi-asserted-by":"publisher","award":["B14038"],"award-info":[{"award-number":["B14038"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600876"],"award-info":[{"award-number":["81600876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81520108009"],"award-info":[{"award-number":["81520108009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621062"],"award-info":[{"award-number":["81621062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CSCR"],"published-print":{"date-parts":[[2021,2,12]]},"abstract":"<jats:sec><jats:title\/><jats:p>Mesenchymal stem cell (MSC) therapy for clinical diseases associated with inflammation and tissue damage has become a progressive treatment strategy. MSCs have unique biological functions, such as homing, immune regulation, and differentiation capabilities, which provide the prerequisites for the treatment of clinical diseases. Oral diseases are often associated with abnormal immune regulation and epithelial tissue damage. In this review, we summarize previous studies that use MSC therapy to treat various oral inflammatory diseases, including oral ulceration, allergic diseases, chemo\/radiotherapy-induced oral mucositis, periodontitis, osteonecrosis of the jaw, Sj\u00f6gren&amp;#039;s syndrome (SS), among other similar diseases. We highlight MSC treatment as a promising approach in the management of oral inflammatory diseases, and discuss the obstacles that remain and must be overcome for MSC treatment to thrive in the future.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1574888x15666200726224132","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T03:33:54Z","timestamp":1595820834000},"page":"165-174","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mesenchymal Stem Cell Therapy for Oral Inflammatory Diseases: Research Progress and Future Perspectives"],"prefix":"10.2174","volume":"16","author":[{"given":"Wang","family":"Gong","sequence":"first","affiliation":[{"name":"State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-9930","authenticated-orcid":true,"given":"Dunfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","volume":"17","author":"Friedenstein A.J.","year":"1974","unstructured":"Friedenstein A.J.; Chailakhyan R.K.; Latsinik N.V.; Panasyuk A.F.; Keiliss-Borok I.V.; Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974,17(4),331-340","journal-title":"Transplantation"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"Uccelli A.","year":"2008","unstructured":"Uccelli A.; Moretta L.; Pistoia V.; Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008,8(9),726-736","journal-title":"Nat Rev Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1177\/0022034512461016","volume":"91","author":"Zhang Q.Z.","year":"2012","unstructured":"Zhang Q.Z.; Nguyen A.L.; Yu W.H.; Le A.D.; Human oral mucosa and gingiva: A unique reservoir for mesenchymal stem cells. J Dent Res 2012,91(11),1011-1018","journal-title":"J Dent Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"Aggarwal S.","year":"2005","unstructured":"Aggarwal S.; Pittenger M.F.; Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005,105(4),1815-1822","journal-title":"Blood"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081922","volume":"20","author":"Abdal Dayem A.","year":"2019","unstructured":"Abdal Dayem A.; Lee S.B.; Kim K.; Production of mesenchymal stem cells through stem cell reprogramming. Int J Mol Sci 2019,20(8)","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"Galipeau J.","year":"2018","unstructured":"Galipeau J.; Sens\u00e9b\u00e9 L.; Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 2018,22(6),824-833","journal-title":"Cell Stem Cell"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.intimp.2010.06.019","volume":"10","author":"Hoogduijn M.J.","year":"2010","unstructured":"Hoogduijn M.J.; Popp F.; Verbeek R.; The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol 2010,10(12),1496-1500","journal-title":"Int Immunopharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/CJI.0000000000000108","volume":"39","author":"Najar M.","year":"2016","unstructured":"Najar M.; Raicevic G.; Crompot E.; The immunomodulatory potential of mesenchymal stromal cells: a story of a regulatory network. J Immunother 2016,39(2),45-59","journal-title":"J Immunother"},{"key":"ref=9","first-page":"3603","volume":"62","author":"Studeny M.","year":"2002","unstructured":"Studeny M.; Marini F.C.; Champlin R.E.; Zompetta C.; Fidler I.J.; Andreeff M.; Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002,62(13),3603-3608","journal-title":"Cancer Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","volume":"65","author":"Nakamizo A.","year":"2005","unstructured":"Nakamizo A.; Marini F.; Amano T.; Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005,65(8),3307-3318","journal-title":"Cancer Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","volume":"21","author":"El Agha E.","year":"2017","unstructured":"El Agha E.; Kramann R.; Schneider R.K.; Mesenchymal stem cells in fibrotic disease. Cell Stem Cell 2017,21(2),166-177","journal-title":"Cell Stem Cell"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","volume":"12","author":"Cipriani P.","year":"2013","unstructured":"Cipriani P.; Carubbi F.; Liakouli V.; Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. Autoimmun Rev 2013,12(7),709-716","journal-title":"Autoimmun Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.autrev.2015.06.005","volume":"14","author":"Mustafa M.B.","year":"2015","unstructured":"Mustafa M.B.; Porter S.R.; Smoller B.R.; Sitaru C.; Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev 2015,14(10),930-951","journal-title":"Autoimmun Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arr.2010.08.005","volume":"10","author":"Si Y.L.","year":"2011","unstructured":"Si Y.L.; Zhao Y.L.; Hao H.J.; Fu X.B.; Han W.D.; MSCs: Biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev 2011,10(1),93-103","journal-title":"Ageing Res Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrrheum.2013.109","volume":"9","author":"Barry F.","year":"2013","unstructured":"Barry F.; Murphy M.; Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol 2013,9(10),584-594","journal-title":"Nat Rev Rheumatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1593\/neo.04169","volume":"6","author":"Naidu M.U.","year":"2004","unstructured":"Naidu M.U.; Ramana G.V.; Rani P.U.; Mohan I.K.; Suman A.; Roy P.; Chemotherapy-induced and\/or radiation therapy-induced oral mucositis-complicating the treatment of cancer. Neoplasia 2004,6(5),423-431","journal-title":"Neoplasia"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1532-3382(12)70051-9","volume":"12","author":"Mays J.W.","year":"2012","unstructured":"Mays J.W.; Sarmadi M.; Moutsopoulos N.M.; Oral manifestations of systemic autoimmune and inflammatory diseases: Diagnosis and clinical management. J Evid Based Dent Pract 2012,12(3)(Suppl.),265-282","journal-title":"J Evid Based Dent Pract"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/odi.12729","volume":"24","author":"Moutsopoulos N.M.","year":"2018","unstructured":"Moutsopoulos N.M.; Moutsopoulos H.M.; The oral mucosa: A barrier site participating in tissue-specific and systemic immunity. Oral Dis 2018,24(1-2),22-25","journal-title":"Oral Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1097\/MD.0000000000009533","volume":"96","author":"Yang S.","year":"2017","unstructured":"Yang S.; Zhang B.; Shi Q.; Liu J.; Xu J.; Huo N.; Association of IL-6-174\u200aG\/C and IL10-1082\u200aG\/A polymorphisms with recurrent aphthous stomatitis risk: A meta-analysis. Medicine (Baltimore) 2017,96(52),9533","journal-title":"Medicine (Baltimore)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/exd.13244","volume":"26","author":"Zhang J.","year":"2017","unstructured":"Zhang J.; Tan Y.Q.; Wei M.H.; TLR4-induced B7-H1 on keratinocytes negatively regulates CD4+ T cells and CD8+ T cells responses in oral lichen planus. Exp Dermatol 2017,26(5),409-415","journal-title":"Exp Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.7812\/TPP\/13-095","volume":"18","author":"Rajan B.","year":"2014","unstructured":"Rajan B.; Ahmed J.; Shenoy N.; Denny C.; Ongole R.; Binnal A.; Assessment of quality of life in patients with chronic oral mucosal diseases: A questionnaire-based study. Perm J 2014,18(1),e123-e127","journal-title":"Perm J"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6831-12-2","volume":"12","author":"Liu L.J.","year":"2012","unstructured":"Liu L.J.; Xiao W.; He Q.B.; Jiang W.W.; Generic and oral quality of life is affected by oral mucosal diseases. BMC Oral Health 2012,12,2","journal-title":"BMC Oral Health"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/stem.2614","volume":"35","author":"Nitzsche F.","year":"2017","unstructured":"Nitzsche F.; M\u00fcller C.; Lukomska B.; Jolkkonen J.; Deten A.; Boltze J.; Concise review: msc adhesion cascade-insights into homing and transendothelial migration. Stem Cells 2017,35(6),1446-1460","journal-title":"Stem Cells"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cdd.2013.158","volume":"21","author":"Ma S.","year":"2014","unstructured":"Ma S.; Xie N.; Li W.; Yuan B.; Shi Y.; Wang Y.; Immunobiology of mesenchymal stem cells. Cell Death Differ 2014,21(2),216-225","journal-title":"Cell Death Differ"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/130763","author":"Sohni A.","year":"2013","unstructured":"Sohni A.; Verfaillie C.M.; Mesenchymal stem cells migration homing and tracking. Stem Cells Int 2013","journal-title":"Stem Cells Int"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1634\/stemcells.2005-0319","volume":"24","author":"Honczarenko M.","year":"2006","unstructured":"Honczarenko M.; Le Y.; Swierkowski M.; Ghiran I.; Glodek A.M.; Silberstein L.E.; Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006,24(4),1030-1041","journal-title":"Stem Cells"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1182\/blood-2004-02-0526","volume":"104","author":"Wynn R.F.","year":"2004","unstructured":"Wynn R.F.; Hart C.A.; Corradi-Perini C.; A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004,104(9),2643-2645","journal-title":"Blood"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.yjmcc.2008.03.010","volume":"44","author":"Steingen C.","year":"2008","unstructured":"Steingen C.; Brenig F.; Baumgartner L.; Schmidt J.; Schmidt A.; Bloch W.; Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol 2008,44(6),1072-1084","journal-title":"J Mol Cell Cardiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3727\/096368910X508762","volume":"19","author":"Yagi H.","year":"2010","unstructured":"Yagi H.; Soto-Gutierrez A.; Parekkadan B.; Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 2010,19(6),667-679","journal-title":"Cell Transplant"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","volume":"101","author":"Krampera M.","year":"2003","unstructured":"Krampera M.; Glennie S.; Dyson J.; Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003,101(9),3722-3729","journal-title":"Blood"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000442579","volume":"235","author":"Relimpio L\u00f3pez M.I.","year":"2016","unstructured":"Relimpio L\u00f3pez M.I.; Espejo Arjona F.; Garrido Hermosilla A.M.; Laborda Guirao T.; G\u00f3mez Escobar A.J.; Rodr\u00edguez de la R\u00faa Franch E.; Surgical Approaches for Vitreomacular Tractions. Ophthalmologica 2016,235(1),62","journal-title":"Ophthalmologica"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2045-3701-2-8","volume":"2","author":"Han Z.","year":"2012","unstructured":"Han Z.; Jing Y.; Zhang S.; Liu Y.; Shi Y.; Wei L.; The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth. Cell Biosci 2012,2(1),8","journal-title":"Cell Biosci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1089\/scd.2013.0479","volume":"23","author":"Zhang B.","year":"2014","unstructured":"Zhang B.; Yin Y.; Lai R.C.; Tan S.S.; Choo A.B.; Lim S.K.; Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev 2014,23(11),1233-1244","journal-title":"Stem Cells Dev"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/s41375-020-0775-3","volume":"34","author":"Xia C.","year":"2020","unstructured":"Xia C.; Wang T.; Cheng H.; Mesenchymal stem cells suppress leukemia via macrophage-mediated functional restoration of bone marrow microenvironment. Leukemia 2020,34(9),2375-2383","journal-title":"Leukemia"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","volume":"74","author":"Li N.","year":"2017","unstructured":"Li N.; Hua J.; Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci 2017,74(13),2345-2360","journal-title":"Cell Mol Life Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"N\u00e9meth K.","year":"2009","unstructured":"N\u00e9meth K.; Leelahavanichkul A.; Yuen P.S.; Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009,15(1),42-49","journal-title":"Nat Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/jcp.21446","volume":"216","author":"Kanichai M.","year":"2008","unstructured":"Kanichai M.; Ferguson D.; Prendergast P.J.; Campbell V.A.; Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: A role for AKT and hypoxia-inducible factor (HIF)-1alpha. J Cell Physiol 2008,216(3),708-715","journal-title":"J Cell Physiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3389\/fimmu.2019.02663","volume":"10","author":"Gomzikova M.O.","year":"2019","unstructured":"Gomzikova M.O.; James V.; Rizvanov A.A.; Therapeutic application of mesenchymal stem cells derived extracellular vesicles for immunomodulation. Front Immunol 2019,10,2663","journal-title":"Front Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00005-016-0453-3","volume":"65","author":"Czernek L.","year":"2017","unstructured":"Czernek L.; D\u00fcchler M.; Functions of cancer-derived extracellular vesicles in immunosuppression. Arch Immunol Ther Exp (Warsz) 2017,65(4),311-323","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5126156","author":"Seo Y.","year":"2019","unstructured":"Seo Y.; Kim H.S.; Hong I.S.; Stem cell-derived extracellular vesicles as immunomodulatory therapeutics. Stem Cells Int 2019","journal-title":"Stem Cells Int"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13287-018-0939-5","volume":"9","author":"Cho B.S.","year":"2018","unstructured":"Cho B.S.; Kim J.O.; Ha D.H.; Yi Y.W.; Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res Ther 2018,9(1),187","journal-title":"Stem Cell Res Ther"},{"key":"ref=42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"Waterman R.S.","year":"2010","unstructured":"Waterman R.S.; Tomchuck S.L.; Henkle S.L.; Betancourt A.M.; A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 2010,5(4)","journal-title":"PLoS One"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/scrt111","volume":"3","author":"Jackson W.M.","year":"2012","unstructured":"Jackson W.M.; Nesti L.J.; Tuan R.S.; Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther 2012,3(3),20","journal-title":"Stem Cell Res Ther"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"Caplan A.I.","year":"2006","unstructured":"Caplan A.I.; Dennis J.E.; Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006,98(5),1076-1084","journal-title":"J Cell Biochem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1089\/scd.2014.0316","volume":"24","author":"Shabbir A.","year":"2015","unstructured":"Shabbir A.; Cox A.; Rodriguez-Menocal L.; Salgado M.; Van Badiavas E.; Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev 2015,24(14),1635-1647","journal-title":"Stem Cells Dev"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cbin.10378","volume":"39","author":"Naderi-Meshkin H.","year":"2015","unstructured":"Naderi-Meshkin H.; Bahrami A.R.; Bidkhori H.R.; Mirahmadi M.; Ahmadiankia N.; Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy. Cell Biol Int 2015,39(1),23-34","journal-title":"Cell Biol Int"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12105-018-0981-8","volume":"13","author":"Fitzpatrick S.G.","year":"2019","unstructured":"Fitzpatrick S.G.; Cohen D.M.; Clark A.N.; Ulcerated lesions of the oral mucosa: Clinical and histologic review. Head Neck Pathol 2019,13(1),91-102","journal-title":"Head Neck Pathol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/stem.503","volume":"28","author":"Zhang Q.Z.","year":"2010","unstructured":"Zhang Q.Z.; Su W.R.; Shi S.H.; Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 2010,28(10),1856-1868","journal-title":"Stem Cells"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/jop.12517","volume":"46","author":"Lee D.Y.","year":"2017","unstructured":"Lee D.Y.; Kim H.B.; Shim I.K.; Kanai N.; Okano T.; Kwon S.K.; Treatment of chemically induced oral ulcer using adipose-derived mesenchymal stem cell sheet. J Oral Pathol Med 2017,46(7),520-527","journal-title":"J Oral Pathol Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.15283\/ijsc18074","volume":"12","author":"Rashed F.M.","year":"2019","unstructured":"Rashed F.M.; GabAllah OM, AbuAli SY, Shredah MT. The effect of using bone marrow mesenchymal stem cells versus platelet rich plasma on the healing of induced oral ulcer in albino rats. Int J Stem Cells 2019,12(1),95-106","journal-title":"Int J Stem Cells"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13287-020-1569-2","volume":"11","author":"Han N.","year":"2020","unstructured":"Han N.; Jia L.; Guo L.; Balanced oral pathogenic bacteria and probiotics promoted wound healing via maintaining mesenchymal stem cell homeostasis. Stem Cell Res Ther 2020,11(1),61","journal-title":"Stem Cell Res Ther"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010515","volume":"97","author":"Li Y.","year":"2018","unstructured":"Li Y.; Wang Z.; Zhao Y.; Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review. Medicine (Baltimore) 2018,97(16)","journal-title":"Medicine (Baltimore)"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0714.2009.00819.x","volume":"39","author":"El-Menoufy H.","year":"2010","unstructured":"El-Menoufy H.; Aly L.A.; Aziz M.T.; The role of bone marrow-derived mesenchymal stem cells in treating formocresol induced oral ulcers in dogs. J Oral Pathol Med 2010,39(4),281-289","journal-title":"J Oral Pathol Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.17796\/jcpd.38.3.193115427jg6vl60","volume":"38","author":"Alamoudi N.M.","year":"2014","unstructured":"Alamoudi N.M.; El Ashiry E.A.; Farsi N.M.; El Derwi D.A.; Atta H.M.; Treatment of oral ulcers in dogs using adipose tissue-derived mesenchymal stem cells. J Clin Pediatr Dent 2014,38(3),215-222","journal-title":"J Clin Pediatr Dent"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0140-6736(04)15592-X","volume":"363","author":"Ling E.M.","year":"2004","unstructured":"Ling E.M.; Smith T.; Nguyen X.D.; Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004,363(9409),608-615","journal-title":"Lancet"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41419-018-0614-x","volume":"9","author":"Chen X.","year":"2018","unstructured":"Chen X.; Liu Q.; Huang W.; Stanniocalcin-2 contributes to mesenchymal stromal cells attenuating murine contact hypersensitivity mainly via reducing CD8+ Tc1 cells. Cell Death Dis 2018,9(5),548","journal-title":"Cell Death Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1593\/neo.04169","volume":"6","author":"Naidu M.U.","year":"2004","unstructured":"Naidu M.U.; Ramana G.V.; Rani P.U.; Mohan I.K.; Suman A.; Roy P.; Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-\u03b21 alleviate atopic dermatitis by reducing mast cell degranulation. Neoplasia 2004,6(5),423-431","journal-title":"Neoplasia"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/stem.738","volume":"29","author":"Su W.R.","year":"2011","unstructured":"Su W.R.; Zhang Q.Z.; Shi S.H.; Nguyen A.L.; Le A.D.; Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E2-dependent mechanisms. Stem Cells 2011,29(11),1849-1860","journal-title":"Stem Cells"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/stem.2401","volume":"35","author":"Kim H.S.","year":"2017","unstructured":"Kim H.S.; Lee J.H.; Roh K.H.; Jun H.J.; Kang K.S.; Kim T.Y.; Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: Phase i\/iia studies. Stem Cells 2017,35(1),248-255","journal-title":"Stem Cells"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13287-016-0361-9","volume":"7","author":"Li P.","year":"2016","unstructured":"Li P.; Zhao Y.; Ge L.; Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E2-EP3 signaling. Stem Cell Res Ther 2016,7(1),103","journal-title":"Stem Cell Res Ther"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.ymthe.2017.04.004","volume":"25","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Huang W.; Chen X.; Cxcr5-overexpressing mesenchymal stromal cells exhibit enhanced homing and can decrease contact hypersensitivity. Mol Ther 2017,25(6),1434-1447","journal-title":"Mol Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1046\/j.1365-2141.2002.03499.x","volume":"117","author":"Hsiao L.T.","year":"2002","unstructured":"Hsiao L.T.; Chung H.M.; Lin J.T.; Stevens-Johnson syndrome after treatment with STI571: A case report. Br J Haematol 2002,117(3),620-622","journal-title":"Br J Haematol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jtos.2015.10.002","volume":"14","author":"Kohanim S.","year":"2016","unstructured":"Kohanim S.; Palioura S.; Saeed H.N.; Stevens-johnson syndrome\/toxic epidermal necrolysis-a comprehensive review and guide to therapy. I. Systemic Disease. Ocul Surf 2016,14(1),2-19","journal-title":"Ocul Surf"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1468-3083.2012.04572.x","volume":"27","author":"Li X.","year":"2013","unstructured":"Li X.; Wang D.; Lu Z.; Chen J.; Zhang H.; Sun L.; Umbilical cord mesenchymal stem cell transplantation in drug-induced Stevens-Johnson syndrome. J Eur Acad Dermatol Venereol 2013,27(5),659-661","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.4317\/medoral.20126","volume":"20","author":"Nagarajan K.","year":"2015","unstructured":"Nagarajan K.; Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment. Med Oral Patol Oral Cir Bucal 2015,20(3),e273-e277","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2016.04.001","volume":"120","author":"Moslemi D.","year":"2016","unstructured":"Moslemi D.; Nokhandani A.M.; Otaghsaraei M.T.; Moghadamnia Y.; Kazemi S.; Moghadamnia A.A.; Management of chemo\/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature. Radiother Oncol 2016,120(1),13-20","journal-title":"Radiother Oncol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jcyt.2014.10.015","volume":"17","author":"Hendijani F.","year":"2015","unstructured":"Hendijani F.; Human mesenchymal stromal cell therapy for prevention and recovery of chemo\/radiotherapy adverse reactions. Cytotherapy 2015,17(5),509-525","journal-title":"Cytotherapy"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00066-013-0510-3","volume":"190","author":"Schmidt M.","year":"2014","unstructured":"Schmidt M.; Haagen J.; Noack R.; Siegemund A.; Gabriel P.; D\u00f6rr W.; Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation. Strahlenther Onkol 2014,190(4),399-404","journal-title":"Strahlenther Onkol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00411-014-0552-7","volume":"53","author":"Schmidt M.","year":"2014","unstructured":"Schmidt M.; Piro-Hussong A.; Siegemund A.; Gabriel P.; D\u00f6rr W.; Modification of radiation-induced oral mucositis (mouse) by adult stem cell therapy: Single-dose irradiation. Radiat Environ Biophys 2014,53(4),629-634","journal-title":"Radiat Environ Biophys"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41419-018-0310-x","volume":"9","author":"Shen Z.","year":"2018","unstructured":"Shen Z.; Wang J.; Huang Q.; Genetic modification to induce CXCR2 overexpression in mesenchymal stem cells enhances treatment benefits in radiation-induced oral mucositis. Cell Death Dis 2018,9(2),229","journal-title":"Cell Death Dis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1089\/scd.2011.0252","volume":"21","author":"Zhang Q.","year":"2012","unstructured":"Zhang Q.; Nguyen A.L.; Shi S.; Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev 2012,21(6),937-947","journal-title":"Stem Cells Dev"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2015.06.012","volume":"366","author":"Nicolay N.H.","year":"2015","unstructured":"Nicolay N.H.; Lopez Perez R.; Debus J.; Huber P.E.; Mesenchymal stem cells \u2013 A new hope for radiotherapy-induced tissue damage? Cancer Lett 2015,366(2),133-140","journal-title":"Cancer Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jcyt.2016.06.008","volume":"18","author":"Maria O.M.","year":"2016","unstructured":"Maria O.M.; Shalaby M.; Syme A.; Eliopoulos N.; Muanza T.; Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis. Cytotherapy 2016,18(9),1129-1145","journal-title":"Cytotherapy"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8634540","author":"Elsaadany B.","year":"2017","unstructured":"Elsaadany B.; El Kholy S.; El Rouby D.; Rashed L.; Shouman T.; Effect of transplantation of bone marrow derived mesenchymal stem cells and platelets rich plasma on experimental model of radiation induced oral mucosal injury in albino rats. Int J Dent 2017","journal-title":"Int J Dent"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/JPER.17-0341","volume":"89","author":"Wei W.","year":"2018","unstructured":"Wei W.; An Y.; An Y.; Fei D.; Wang Q.; Activation of autophagy in periodontal ligament mesenchymal stem cells promotes angiogenesis in periodontitis. J Periodontol 2018,89(6),718-727","journal-title":"J Periodontol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1902\/jop.2004.75.9.1281","volume":"75","author":"Kawaguchi H.","year":"2004","unstructured":"Kawaguchi H.; Hirachi A.; Hasegawa N.; Enhancement of periodontal tissue regeneration by transplantation of bone marrow mesenchymal stem cells. J Periodontol 2004,75(9),1281-1287","journal-title":"J Periodontol"},{"key":"ref=77","first-page":"363","volume":"26","author":"Yamada Y.","year":"2006","unstructured":"Yamada Y.; Ueda M.; Hibi H.; Baba S.; A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma using tissue engineering technology: A clinical case report. Int J Periodontics Restorative Dent 2006,26(4),363-369","journal-title":"Int J Periodontics Restorative Dent"},{"key":"ref=78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040944","volume":"19","author":"Hern\u00e1ndez-Monjaraz B.","year":"2018","unstructured":"Hern\u00e1ndez-Monjaraz B.; Santiago-Osorio E.; Monroy-Garc\u00eda A.; Ledesma-Mart\u00ednez E.; Mendoza-N\u00fa\u00f1ez V.M.; Mesenchymal stem cells of dental origin for inducing tissue regeneration in periodontitis: A mini-review. Int J Mol Sci 2018,19(4)","journal-title":"Int J Mol Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.intimp.2017.11.028","volume":"54","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Xiong Y.; Chen X.; Chen C.; Zhu Z.; Li L.; Therapeutic effect of bone marrow mesenchymal stem cells pretreated with acetylsalicylic acid on experimental periodontitis in rats. Int Immunopharmacol 2018,54,320-328","journal-title":"Int Immunopharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.reth.2019.12.011","volume":"14","author":"Ouchi T.","year":"2020","unstructured":"Ouchi T.; Nakagawa T.; Mesenchymal stem cell-based tissue regeneration therapies for periodontitis. Regen Ther 2020,14,72-78","journal-title":"Regen Ther"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000166547","volume":"190","author":"Li H.","year":"2009","unstructured":"Li H.; Yan F.; Lei L.; Li Y.; Xiao Y.; Application of autologous cryopreserved bone marrow mesenchymal stem cells for periodontal regeneration in dogs. Cells Tissues Organs (Print) 2009,190(2),94-101","journal-title":"Cells Tissues Organs (Print)"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1177\/0022034513498258","volume":"92","author":"Hynes K.","year":"2013","unstructured":"Hynes K.; Menicanin D.; Han J.; Mesenchymal stem cells from iPS cells facilitate periodontal regeneration. J Dent Res 2013,92(9),833-839","journal-title":"J Dent Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/0022034513513026","volume":"93","author":"Du J.","year":"2014","unstructured":"Du J.; Shan Z.; Ma P.; Wang S.; Fan Z.; Allogeneic bone marrow mesenchymal stem cell transplantation for periodontal regeneration. J Dent Res 2014,93(2),183-188","journal-title":"J Dent Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/idj.12318","volume":"68","author":"Chronopoulos A.","year":"2018","unstructured":"Chronopoulos A.; Zarra T.; Ehrenfeld M.; Otto S.; Osteoradionecrosis of the jaws: Definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J 2018,68(1),22-30","journal-title":"Int Dent J"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.coms.2014.02.002","volume":"26","author":"McCaul J.A.","year":"2014","unstructured":"McCaul J.A.; Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw. Oral Maxillofac Surg Clin North Am 2014,26(2),247-252","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3727\/096368911X637434","volume":"21","author":"Xu J.","year":"2012","unstructured":"Xu J.; Zheng Z.; Fang D.; Mesenchymal stromal cell-based treatment of jaw osteoradionecrosis in Swine. Cell Transplant 2012,21(8),1679-1686","journal-title":"Cell Transplant"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/2231-0746.147130","volume":"4","author":"Manimaran K.","year":"2014","unstructured":"Manimaran K.; Sankaranarayanan S.; Ravi V.R.; Elangovan S.; Chandramohan M.; Perumal S.M.; Treatment of osteoradionecrosis of mandible with bone marrow concentrate and with dental pulp stem cells. Ann Maxillofac Surg 2014,4(2),189-192","journal-title":"Ann Maxillofac Surg"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev.med.60.063007.134350","volume":"60","author":"Ruggiero S.L.","year":"2009","unstructured":"Ruggiero S.L.; Mehrotra B.; Bisphosphonate-related osteonecrosis of the jaw: Diagnosis, prevention, and management. Annu Rev Med 2009,60,85-96","journal-title":"Annu Rev Med"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1089\/scd.2012.0615","volume":"22","author":"Li Y.","year":"2013","unstructured":"Li Y.; Xu J.; Mao L.; Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine. Stem Cells Dev 2013,22(14),2047-2056","journal-title":"Stem Cells Dev"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jbmr.37","volume":"25","author":"Kikuiri T.","year":"2010","unstructured":"Kikuiri T.; Kim I.; Yamaza T.; Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 2010,25(7),1668-1679","journal-title":"J Bone Miner Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bone.2015.01.011","volume":"74","author":"Ogata K.","year":"2015","unstructured":"Ogata K.; Katagiri W.; Osugi M.; Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model. Bone 2015,74,95-105","journal-title":"Bone"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.actbio.2016.06.022","volume":"42","author":"Kaibuchi N.","year":"2016","unstructured":"Kaibuchi N.; Iwata T.; Yamato M.; Okano T.; Ando T.; Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model. Acta Biomater 2016,42,400-410","journal-title":"Acta Biomater"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/0194599816688647","volume":"156","author":"Janus J.R.","year":"2017","unstructured":"Janus J.R.; Jackson R.S.; Lees K.A.; Human adipose-derived mesenchymal stem cells for osseous rehabilitation of induced osteoradionecrosis: A Rodent Model. Otolaryngol Head Neck Surg 2017,156(4),616-621","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hed.25004","volume":"40","author":"Park H.S.","year":"2018","unstructured":"Park H.S.; Lee J.; Kim J.W.; Preventive effects of tonsil-derived mesenchymal stem cells on osteoradionecrosis in a rat model. Head Neck 2018,40(3),526-535","journal-title":"Head Neck"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"Fox R.I.","year":"2005","unstructured":"Fox R.I.; Sj\u00f6gren\u2019s syndrome. Lancet 2005,366(9482),321-331","journal-title":"Lancet"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.berh.2016.04.003","volume":"30","author":"Rischmueller M.","year":"2016","unstructured":"Rischmueller M.; Tieu J.; Lester S.; Primary Sj\u00f6gren\u2019s syndrome. Best Pract Res Clin Rheumatol 2016,30(1),189-220","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"Christodoulou M.I.","year":"2010","unstructured":"Christodoulou M.I.; Kapsogeorgou E.K.; Moutsopoulos H.M.; Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome. J Autoimmun 2010,34(4),400-407","journal-title":"J Autoimmun"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","volume":"182","author":"Goules A.V.","year":"2017","unstructured":"Goules A.V.; Kapsogeorgou E.K.; Tzioufas A.G.; Insight into pathogenesis of Sj\u00f6gren\u2019s syndrome: Dissection on autoimmune infiltrates and epithelial cells. Clin Immunol 2017,182,30-40","journal-title":"Clin Immunol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1067\/moe.2003.30","volume":"95","author":"Khurshudian A.V.","year":"2003","unstructured":"Khurshudian A.V.; A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sj\u00f6gren\u2019s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003,95(1),38-44","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/rheumatology\/keu316","volume":"54","author":"Liu R.","year":"2015","unstructured":"Liu R.; Su D.; Zhou M.; Feng X.; Li X.; Sun L.; Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sj\u00f6gren\u2019s syndrome through the secretion of indoleamine 2,3-dioxygenase. Rheumatology (Oxford) 2015,54(2),332-342","journal-title":"Rheumatology (Oxford)"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/ard.2009.115378","volume":"69","author":"Roescher N.","year":"2010","unstructured":"Roescher N.; Tak P.P.; Illei G.G.; Cytokines in Sjogren\u2019s syndrome: Potential therapeutic targets. Ann Rheum Dis 2010,69(6),945-948","journal-title":"Ann Rheum Dis"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.2010.1014","volume":"304","author":"Ramos-Casals M.","year":"2010","unstructured":"Ramos-Casals M.; Tzioufas A.G.; Stone J.H.; Sis\u00f3 A.; Bosch X.; Treatment of primary Sj\u00f6gren syndrome: A systematic review. JAMA 2010,304(4),452-460","journal-title":"JAMA"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"Xu J.","year":"2012","unstructured":"Xu J.; Wang D.; Liu D.; Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood 2012,120(15),3142-3151","journal-title":"Blood"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13287-018-1023-x","volume":"9","author":"Shi B.","year":"2018","unstructured":"Shi B.; Qi J.; Yao G.; Mesenchymal stem cell transplantation ameliorates Sj\u00f6gren\u2019s syndrome via suppressing IL-12 production by dendritic cells. Stem Cell Res Ther 2018,9(1),308","journal-title":"Stem Cell Res Ther"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2019.1707996","volume":"7","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Li C.; Wang S.; Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sj\u00f6gren\u2019s syndrome by inducing regulatory T cells. Mod Rheumatol 2020,7,1-11","journal-title":"Mod Rheumatol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41419-020-2359-6","volume":"11","author":"Hu L.","year":"2020","unstructured":"Hu L.; Xu J.; Wu T.; Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sj\u00f6gren\u2019s syndrome. Cell Death Dis 2020,11(3),172","journal-title":"Cell Death Dis"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"Ferrara J.L.","year":"2009","unstructured":"Ferrara J.L.; Levine J.E.; Reddy P.; Holler E.; Graft-versus-host disease. Lancet 2009,373(9674),1550-1561","journal-title":"Lancet"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.exphem.2016.05.011","volume":"44","author":"Vriesendorp H.M.","year":"2016","unstructured":"Vriesendorp H.M.; Heidt P.J.; History of graft-versus-host disease. Exp Hematol 2016,44(8),674-688","journal-title":"Exp Hematol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","volume":"100","author":"Flowers M.E.","year":"2002","unstructured":"Flowers M.E.; Parker P.M.; Johnston L.J.; Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: Long-term follow-up of a randomized trial. Blood 2002,100(2),415-419","journal-title":"Blood"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","volume":"102","author":"Mielcarek M.","year":"2003","unstructured":"Mielcarek M.; Martin P.J.; Leisenring W.; Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003,102(2),756-762","journal-title":"Blood"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.tripleo.2005.08.028","volume":"101","author":"Imanguli M.M.","year":"2006","unstructured":"Imanguli M.M.; Pavletic S.Z.; Guadagnini J.P.; Brahim J.S.; Atkinson J.C.; Chronic graft versus host disease of oral mucosa: Review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006,101(2),175-183","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/imj.12812","volume":"45","author":"Hull K.","year":"2015","unstructured":"Hull K.; Kerridge I.; Avery S.; McCullough M.; Ritchie D.; Szer J.; Oral chronic graft-versus-host disease in Australia: Clinical features and challenges in management. Intern Med J 2015,45(7),702-710","journal-title":"Intern Med J"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/14656566.2017.1282464","volume":"18","author":"Zadik Y.","year":"2017","unstructured":"Zadik Y.; Elad S.; Shapira A.; Shapira M.Y.; Treatment of oral mucosal manifestations of chronic graft-versus-host disease: Dexamethasone vs. budesonide. Expert Opin Pharmacother 2017,18(3),235-242","journal-title":"Expert Opin Pharmacother"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.bbmt.2018.02.022","volume":"24","author":"Elad S.","year":"2018","unstructured":"Elad S.; Zinchuk K.; Li S.; Cutler C.; Liesveld J.; Treister N.S.; Economic and practical considerations in the treatment of oral mucosal chronic graft-versus-host disease. Biol Blood Marrow Transplant 2018,24(8),1748-1753","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"Le Blanc K.","year":"2008","unstructured":"Le Blanc K.; Frassoni F.; Ball L.; developmental committee of the european group for blood and marrow transplantation. mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase ii study. Lancet 2008,371(9624),1579-1586","journal-title":"Lancet"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jcyt.2013.10.012","volume":"16","author":"Jang Y.K.","year":"2014","unstructured":"Jang Y.K.; Kim M.; Lee Y.H.; Oh W.; Yang Y.S.; Choi S.J.; Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease. Cytotherapy 2014,16(3),298-308","journal-title":"Cytotherapy"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/leu.2014.225","volume":"29","author":"Peng Y.","year":"2015","unstructured":"Peng Y.; Chen X.; Liu Q.; Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia 2015,29(3),636-646","journal-title":"Leukemia"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"Baumgart D.C.","year":"2012","unstructured":"Baumgart D.C.; Sandborn W.J.; Crohn\u2019s disease. Lancet 2012,380(9853),1590-1605","journal-title":"Lancet"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5009\/gnl17035","volume":"12","author":"Zhang J.","year":"2018","unstructured":"Zhang J.; Lv S.; Liu X.; Song B.; Shi L.; Umbilical cord mesenchymal stem cell treatment for crohn\u2019s disease: a randomized controlled clinical trial. Gut Liver 2018,12(1),73-78","journal-title":"Gut Liver"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cellimm.2013.11.003","volume":"286","author":"Bandzar S.","year":"2013","unstructured":"Bandzar S.; Gupta S.; Platt M.O.; Crohn\u2019s disease: A review of treatment options and current research. Cell Immunol 2013,286(1-2),45-52","journal-title":"Cell Immunol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.oooo.2016.03.018","volume":"122","author":"Ma H.","year":"2016","unstructured":"Ma H.; Wu Y.; Yang H.; MicroRNAs in oral lichen planus and potential miRNA-mRNA pathogenesis with essential cytokines: A review. Oral Surg Oral Med Oral Pathol Oral Radiol 2016,122(2),164-173","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mcna.2014.08.006","volume":"98","author":"Stoopler E.T.","year":"2014","unstructured":"Stoopler E.T.; Sollecito T.P.; Oral mucosal diseases: Evaluation and management. Med Clin North Am 2014,98(6),1323-1352","journal-title":"Med Clin North Am"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jop.12224","volume":"44","author":"Zhang Z.","year":"2015","unstructured":"Zhang Z.; Han Y.; Song J.; Interferon-\u03b3 regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity. J Oral Pathol Med 2015,44(1),15-27","journal-title":"J Oral Pathol Med"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/cancers7020816","volume":"7","author":"Rothschild S.I.","year":"2015","unstructured":"Rothschild S.I.; Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK. Cancers (Basel) 2015,7(2),930-949","journal-title":"Cancers (Basel)"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/path.2809","volume":"223","author":"Flavin R.","year":"2011","unstructured":"Flavin R.; Zadra G.; Loda M.; Metabolic alterations and targeted therapies in prostate cancer. J Pathol 2011,223(2),283-294","journal-title":"J Pathol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","volume":"35","author":"Wang Z.","year":"2015","unstructured":"Wang Z.; Dabrosin C.; Yin X.; Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 2015,35(Suppl.),S224-S243","journal-title":"Semin Cancer Biol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaad.2014.12.028","volume":"72","author":"Arkin L.M.","year":"2015","unstructured":"Arkin L.M.; Ansell L.; Rademaker A.; The natural history of pediatric-onset discoid lupus erythematosus. J Am Acad Dermatol 2015,72(4),628-633","journal-title":"J Am Acad Dermatol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.ijwd.2017.02.013","volume":"3","author":"Haber J.S.","year":"2017","unstructured":"Haber J.S.; Merola J.F.; Werth V.P.; Classifying discoid lupus erythematosus: Background, gaps, and difficulties. Int J Womens Dermatol 2017,3(1)(Suppl.),S62-S66","journal-title":"Int J Womens Dermatol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0961203317711013","volume":"27","author":"Yang X.","year":"2018","unstructured":"Yang X.; Yang J.; Li X.; Ma W.; Zou H.; Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice. Lupus 2018,27(1),49-59","journal-title":"Lupus"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"41258","DOI":"10.1038\/srep41258","volume":"7","author":"Lee H.K.","year":"2017","unstructured":"Lee H.K.; Kim H.S.; Kim J.S.; CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms. Sci Rep 2017,7,41258","journal-title":"Sci Rep"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/art.33313","volume":"64","author":"Choi E.W.","year":"2012","unstructured":"Choi E.W.; Shin I.S.; Park S.Y.; Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum 2012,64(1),243-253","journal-title":"Arthritis Rheum"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/cmi.2008.52","volume":"5","author":"Zhou K.","year":"2008","unstructured":"Zhou K.; Zhang H.; Jin O.; Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice. Cell Mol Immunol 2008,5(6),417-424","journal-title":"Cell Mol Immunol"}],"container-title":["Current Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184122","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184122\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T20:37:41Z","timestamp":1723322261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184122\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":132,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574888x15666200726224132","relation":{},"ISSN":["1574-888X"],"issn-type":[{"value":"1574-888X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}